Cost Conscious Project: How Many Troponins Does It Take? Rola Khedraki.

Slides:



Advertisements
Similar presentations
Patient Oriented Therapy Non STE ACS
Advertisements

1 Lecture | Dr. Usman Ghani
Early assessment of myocardial injury by joint measurement of TnT-hs and Copeptin (1) J. Teixeira, (2) P. Wotquenne, (2) V. D’Orio, (3) D. Gruson, (1)
Tobias Reichlin, W. Hochholzer, C. Stelzig, K. Laule, M. Potocki, K
The Macstrak Project CCU Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
Acute coronary syndrome : Risk stratification – markers of myocardial necrosis Paul Calle Emergency Department Ghent University Hospital Belgium.
Isoenzymes and Other Markers Mike Clark, M.D.. Isozymes (also known as isoenzymes) are enzymes that differ in amino acid sequence but catalyze the same.
TEMPLATE DESIGN © Introduction Blunt cardiac injury (BCI) in the setting of blunt chest trauma brings about much discussion.
Troponin Use in A&E/EAU
High Sensitivity Troponin
The Macstrak Project Ward Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
Approach to Chest Pain. History “When it comes to chest pain, if you aren’t confident with your diagnosis after your history, take it again” Dr. M. Gamble.
ACUTE CORONARY SYNDORME EARLY RISK STRATIFICATION Sarah Jamison March 2003.
OnSite Troponin I Rapid Test. Cardiac markers are biomarkers measured to evaluate heart function.biomarkers They are often discussed in the context of.
Myocardial infarction biomarkers Lecture 5. Cases 1 Middle aged man referred by family doctor to a dermatologist because of extensive yellow papules with.
Acute Coronary Syndrome. Acute Coronary Syndrome (ACS) Definition of ACS Signs and symptoms of ACS Gender and age related difference in ACS Pathophysiology.
1 Dr. Zahoor Ali Shaikh. 2 CORONARY ARTERY DISEASE (CAD)  CAD is most common form of heart disease and causes premature death.  In UK, 1 in 3 men and.
Clinical Correlations The NYU Internal Medicine Blog A Daily Dose of Medicine
Biochemical Markers of Myocardial Infarction
The Heart of the Matter A Journey through the system of care.
CRUSADE: A National Quality Improvement Initiative CRUSADE: A National Quality Improvement Initiative Can Rapid Risk Stratification of Unstable Angina.
1 DIAGNOSTICS OF Acute Coronary Syndromes At the end of this self study the participant will: Verbalize meanings of specific ECG changes: –ST Elevation.
Medical Grand Rounds Clinical Vignette October 15 th, 2008 Srikant Duggirala, M.D.
A 2-hour Accelerated Diagnostic Protocol to Assess Patients With Chest Pain Symptoms Using Contemporary Troponins as the Only Bbiomarker (ADAPT) Martin.
Ischemic Heart Disease CVS3 Hisham Alkhalidi. Ischemic Heart Disease A group of related syndromes resulting from myocardial ischemia.
Sex-Specific Chest Pain Characteristics in AMI Jay Mansfield, Pgy-3 July 22, 2014 LSU Journal Club Gimenez, M, et. Al. Jama Int Med. 2014;174(2):
Please press F5 on your keyboard to enter presentation mode Welcome to the Eastern Health Pathology guide to hsTnT. The information in this presentation.
Observation Status Medicare Rules
Sensitivity is True positives 60 Total CAD 100 Sensitivity and Specificity CAD by CAG No CAD by CAG TMT + VE True Positives 60 False Positives 60 TMT –
Biochemical Markers for Diagnosis of Myocardial Infarction Cardiovascular Block Medical Biochemistry Course Dr. Reem M. Sallam, MD, PhD.
ACUTE CORONARY SYNDROMES Part I. Definition Acute coronary syndrome (ACS) describes a spectrum of clinical conditions ranging from ST segment elevation.
Absolute and Relative Kinetic Changes of High-Sensitivity Cardiac Troponin T in Acute Coronary Syndrome and in Patients with Increased Troponin in the.
Introduction Left bundle branch block (LBBB) is notorious for obscuring the ECG diagnosis of acute myocardial infarction (AMI) and, therefore, the decision.
Biochemical Investigations In Heart Disaeses
Enzymes, Cardiac Markers, Hepatic Tests clinically useful enzymes: tissue sources preanalytical variables affecting enzyme activities isoenzymes myocardial.
Ischaemic Heart Disease CASE A. CASE A: Mr HA, aged 60 years, was brought in to A&E complaining of chest pain, nausea and a suspected AMI.
Atypical Presentations Patients older than 75: frequently no chest pain ECG in evolution (nonspecific ECG changes) Diabetic patients: commonly no chest.
Journal Club Optimizing Early Rule-Out Strategies for Acute Myocardial Infarction: Utility of 1-Hour Copeptin P. Hillinger, R. Twerenbold, C. Jaeger, K.
Implementation of a Sensitive Troponin I Assay and Risk of Recurrent Myocardial Infarction and Death in Patients With Suspected Acute Coronary Syndrome.
By Julia Kao UCIMC Dept of Internal Medicine 6/3/13 Pattern of troponin ordering by ED among patients admitted to inpatient medicine.
Biochemical Markers of Myocardial Infarction
Spectrum of Acute Coronary Syndromes: Laboratory Findings in Q-Wave AMI Creatine kinase evidence of necrosis NonePositive ECG early ST-segment depression.
Biochemical Markers for Diagnosis of Myocardial Infarction
Ischemic Heart Disease CVS3 Hisham Alkhalidi. Ischemic Heart Disease A group of related syndromes resulting from myocardial ischemia.
RESEARCH POSTER PRESENTATION DESIGN © Cardiac Troponin Assay Cardiac troponin I is the diagnostic marker used for myocardial.
Myocardial Infarction Angina Pectoris What is an MI?
Troponin By Julie Moore C Dt204/2.
Chest Pain in the Emergency Department Junior Teaching C. Brown August 2015.
Cost Containment: Use of Troponin testing in the Inpatient Wards Setting Neal Kaushal, R2 DSR2, May 2013.
Risk Stratification of Chest Pain: Best Practices
Biochemical Investigations In Heart Disaeses
Coronary artery disease
CORONARY ARTERY DISEASE
Tobias Reichlin, M. D. , Willibald Hochholzer, M. D
Cost Effective Use of Troponin to Rule Out Acute Coronary Syndrome
Coronary artery disease
Cardiac Troponin.
Coronary Artery Disease 2
Chapter 28 Management of Patients With Coronary Vascular Disorders
Cardiac enzymes and cardiac proteins
Section A: Introduction
Part I: A Sensible Approach to Sensitive Troponin
Nat. Rev. Cardiol. doi: /nrcardio
Advancing Acute Coronary Syndrome Assessment:
The European Society of Cardiology Presented by RJ De Winter
Kevin R. King et al. BTS 2016;1:73-86
Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Nadia Bandstein, MD; Rickard Ljung,
Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Nadia Bandstein, MD; Rickard Ljung,
High Sensitivity Troponin (hsTnT) : Result Interpretation Matrix*
Presentation transcript:

Cost Conscious Project: How Many Troponins Does It Take? Rola Khedraki

Study Question: Do we really need three troponins in low risk patients?

Who is low risk? Low-risk patients for ACS are those with no hemodynamic derangements or arrhythmias, a normal or near-normal ECG, and negative initial cardiac injury markers.

Objectives Purpose of the study was to ascertain whether troponin tests are requested appropriately.

What’s the Problem and What’s the Evidence? Housestaff often order 3 or sometimes even 4 troponin values to rule out MI in these low risk patients However, for patients who present early (within 6 hours of symptom onset), with negative initial troponin, a second negative measurement 6-8h later is adequate to exclude ACS. And in fact, patients who arrive >8h after symptom onset may only need one negative biomarker to exclude ACS. Amsterdam, et al. Testing of low risk patients presenting to the emergency department with chest pain. Circulation. 2010; 122:

Troponin Assay Occurrence of first increase values after MI symptom onset: 50% of patients at 3.5h75% of patients at 4.3h95% of patients at 7h Mair J, Morandell D, Genser N, Lechleitner P, Dienstl F, Puschendorf B: Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponins I and T for acute myocardial infarction. Clin Chem 1995;41: A negative troponin assay does not exclude diagnosis of unstable angina if obtained within less than 6h

Cost and Implications Healthcare Bluebook: $26 – Can cost 3-5x as much depending on the location Adds to length of stay Inappropriate utilization of resources: Someone has to check on the levels (overnight residents, etc.), nursing staff to draw level Add in cost of EKG with each troponin Pain to patient (frequent lab draw) Test not 100% specific  could result in minimally positive levels and starting antiplatelet therapy  possibly unnecessary complications (esp., in elderly or those with high risk of falls, aortic dissection)

Methods ED to general medicine admissions over time span of 6 days Patients who presented with chest pain (not necessarily chief complaint) All had normal EKG, hemodynamically stable, initial troponin negative

Results Presenting associated symptoms* Hours after symptom onset # of Troponins Final diagnosisAntiplatelets? Epigastric pain18h2 (0:00, 6:00) ConstipationNO Generalized fatigue 24h4 (0:00, 10:00, 16:00, 24:00) InfluenzaNO Syncope8h3 (0:00, 6:00, 12:00) DehydrationYES Fall1h3 (0:00, 4:00, 10:00) Femoral fractureNO Shortness of breath 36h3 (0:00, 6:00, 14:00) COPD exacerbationNO Fall18h2 (0:00, 12:00) Mechanical fallYES Palpitations48h3 (0:00, 6:00, 12:00) Atrial fibrillationNO *All patients presented with chest pain and the following associated symptoms

Discussion Management strategy should be individualized based on clinical presentation and assessment of risk There is little value in obtaining delayed troponin compared to testing at presentation.

Cost Effective Approaches Low risk patients are increasingly managed with accelerated diagnostic protocols. Patients with negative findings complete the protocol with a confirmatory test to exclude ischemia (exercise treadmill or cardiac imaging) done either inpatient or within 72h of discharge.